Xerostomia (Dry Mouth) Market
Xerostomia (Dry Mouth) Market Size, Share & Trends Analysis by Product (Artificial Saliva / Saliva Substitutes, Salivary Stimulants / Sialogogues, Biologic / Regenerative Therapies), By Drug Type (Over?the?Counter (OTC), and Prescription), By Formulation (Sprays, Mouthwashes / Rinses, Gels, Lozenges / Tablets, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies / E?commerce), Forecast Period (2026-2035)
Industry Overview
Xerostomia (dry mouth) market was valued at $1.1 billion in 2025 and is projected to reach $2.2 billion by 2035, growing at a CAGR of 7.1% during the forecast Period (2026-2035). The market focuses on products and therapies that relieve dry mouth symptoms caused by aging, medications, or medical conditions such as Sjögren’s syndrome. The market includes artificial saliva, salivary stimulants, and oral gels, sprays, lozenges, and rinses, offered through prescription and over-the-counter channels. Growing awareness of oral health, an aging population, and rising prevalence of chronic diseases are driving demand. Continuous product innovations and regulatory approvals are expected to support steady market growth in the coming years.
Market Dynamics
Rising Prevalence of Xerostomia and Related Health Conditions
A major driver of the global xerostomia market is the increasing incidence of conditions that either cause or exacerbate dry mouth symptoms. Chronic diseases such as Sj?gren’s syndrome, diabetes, and other autoimmune disorders are associated with reduced salivary gland function, contributing significantly to xerostomia prevalence. In addition, the growing use of chemotherapy and radiotherapy for head and neck cancers has led to higher rates of treatment?induced dry mouth, as these therapies can damage salivary tissues and reduce saliva production. This expanding patient population seeking relief for persistent oral dryness is creating heightened demand for therapeutic solutions, including artificial saliva, salivary stimulants, and related products.
Expanding Geriatric Population and Medication?Induced Dry Mouth
The global aging trend is another significant driver of market growth. Older adults naturally experience a decline in salivary gland function and are more likely to be on multiple medications (polypharmacy), many of which have dry mouth as a side effect. This is particularly important because numerous commonly prescribed drugs such as antihypertensives, antidepressants, antihistamines, and diuretics can reduce salivary flow, compounding the problem in elderly populations. With the number of individuals aged 65 and over projected to grow substantially worldwide, the prevalence of xerostomia is expected to rise, which fuels demand for dry mouth management products across both over?the?counter (OTC) and prescription categories.
Growing Awareness, Improved Diagnosis, and Product Innovation
Increasing awareness about the impacts of xerostomia on oral health such as increased risk of dental caries, infections, difficulty swallowing, and taste changes is driving more patients to seek effective treatments. Enhanced diagnostic practices by healthcare professionals and public health education campaigns have contributed to higher identification rates of dry mouth, encouraging earlier and more sustained treatment. Simultaneously, product innovation including advanced artificial saliva formulations with improved moisture retention, saliva stimulants, and novel delivery formats (gels, sprays, lozenges) is expanding therapeutic options, improving patient compliance, and attracting new users to the market. These innovations, along with expanded distribution channels such as online pharmacies and e?commerce platforms, are facilitating broader access and uptake of xerostomia relief products.
Market Segmentation
- Based on the product, the market is segmented into artificial saliva/saliva substitutes, salivary stimulants/sialogogues, and biologic/regenerative therapies.
- Based on the drug type, the market is segmented into over?the?counter (OTC), and prescription.
- Based on the formulation, the market is segmented into sprays, mouthwashes/rinses, gels, lozenges/tablets, and others.
- Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies & drug stores, and online pharmacies/e-commerce.
Artificial Saliva / Saliva Substitutes Segment to Grow at a Considerable Market Share
The artificial saliva/saliva substitutes segment is expected to lead the Global Xerostomia (Dry Mouth) Market during the forecast period, holding the largest share across all categories. This dominance is primarily driven by the immediate and effective relief these products provide for dry mouth symptoms, making them the preferred choice for patients across age groups and geographies. Artificial saliva formulations closely mimic natural saliva, helping to maintain oral moisture, reduce discomfort, and prevent complications such as dental caries, oral infections, and difficulty swallowing.
The increasing prevalence of xerostomia due to aging populations, widespread polypharmacy, and chronic diseases like diabetes and Sjögren’s syndrome has significantly bolstered demand for artificial saliva. In addition, the product’s availability in multiple convenient forms, such as sprays, gels, lozenges, and rinses, enhances patient compliance and accessibility. Over-the-counter availability further strengthens its market position, as consumers can quickly purchase these solutions without a prescription, supporting broader adoption in both developed and emerging markets.
Moreover, continuous product innovation in artificial saliva, including long-acting formulations and biologically inspired substitutes, has expanded its efficacy and appeal, reinforcing its leadership in the market. Coupled with growing awareness of xerostomia management and increased online distribution through e-commerce channels, artificial saliva/saliva substitutes are poised to remain the largest and most influential segment in the global xerostomia market.
Over-the-Counter (OTC): A Key Segment in Market Growth
The over-the-counter (OTC) segment is the key growth driver in the global xerostomia (dry mouth) market. OTC products, including artificial saliva, mouth sprays, gels, and lozenges, dominate market expansion due to their easy accessibility, convenience, and affordability for patients experiencing mild to moderate dry mouth symptoms. Increasing consumer awareness of oral health and the risks associated with untreated xerostomia, such as dental caries, oral infections, and difficulty swallowing, has led more individuals to seek self-managed solutions without the need for a prescription. Moreover, the growing geriatric population, coupled with widespread use of medications that induce dry mouth, has further accelerated demand for OTC therapies. Product innovations, such as long-lasting moisturizing sprays and flavored lozenges, have enhanced patient compliance and satisfaction, making OTC options more appealing.
Additionally, the rapid expansion of online pharmacies and e-commerce platforms has significantly improved accessibility, allowing consumers to purchase xerostomia products conveniently from home. As a result, OTC formulations are expected to maintain robust growth throughout the forecast period, outpacing prescription drugs and other treatment modalities, and firmly establishing themselves as the primary segment driving revenue in the global xerostomia market.
Regional Outlook
The global xerostomia (dry mouth) market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Region to Hold a Substantial Growth Rate
In North America, the US dominates the global Xerostomia (Dry Mouth) market, driven by a combination of high disease prevalence, advanced healthcare infrastructure, and broad therapeutic adoption. A significant portion of the population experiences dry mouth due to factors such as widespread use of prescription medications, autoimmune disorders, and cancer treatments like radiotherapy that damage salivary glands. These clinical drivers, along with a large and growing elderly demographic, have increased demand for both over?the?counter and prescription xerostomia treatments. North America, as a region, is consistently identified as the leading market globally, with the US accounting for the vast majority of regional demand thanks to strong research and development activities and an established oral healthcare ecosystem. The presence of major pharmaceutical and oral care companies further reinforces its leadership position, as they continue to innovate and expand product portfolios tailored to xerostomia management.
Additionally, effective awareness campaigns, healthcare coverage programs, and easy accessibility through hospital, retail, and online pharmacy channels support higher treatment penetration and patient compliance, solidifying the US pivotal role in shaping market trends and growth globally.
Market Players Outlook
The major companies operating in the global xerostomia (dry mouth) market include Church & Dwight Co., Inc., Colgate-Palmolive Co., GlaxoSmithKline plc (GSK), Hikma Pharmaceuticals PLC, and Sun Pharmaceutical Industries Ltd., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products to maintain their market positioning.
Recent Development
- In March 2026, Zydus Lifesciences received final approval from the US Food and Drug Administration (USFDA) for Cevimeline Hydrochloride Capsules 30?mg, indicated for symptomatic treatment of dry mouth (xerostomia) in patients with Sjögren’s syndrome. This generic equivalent of Evoxac expands treatment options in the US market and supports increased access to an established xerostomia therapy.
- In December 2025, Bio?Inspired Hydrogel for Xerostomia Researchers developed a novel bio?inspired lubricant hydrogel that mimics saliva to relieve dry mouth symptoms without extra lipids. This has potential applications for elderly patients with xerostomia and could lead to alternative therapeutic products.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global xerostomia (dry mouth) market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Xerostomia (Dry Mouth) Market Sales Analysis – Product | Drug Type | Formulation | Distribution Channel ($ Million)
- Xerostomia (Dry Mouth) Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Xerostomia (Dry Mouth) Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Xerostomia (Dry Mouth) Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Xerostomia (Dry Mouth) Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Xerostomia (Dry Mouth) Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Xerostomia (Dry Mouth) Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Xerostomia (Dry Mouth) Market Revenue and Share by Manufacturers
- Xerostomia (Dry Mouth) Drug Type Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Church & Dwight Co., Inc.
- Overview
- Drug Type Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Colgate-Palmolive Co.
- Overview
- Drug Type Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- GlaxoSmithKline plc (GSK)
- Overview
- Drug Type Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Hikma Pharmaceuticals PLC
- Overview
- Drug Type Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Sun Pharmaceutical Industries Ltd.
- Overview
- Drug Type Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Drug Type Launch
- Partnership And Collaboration
- Church & Dwight Co., Inc.
- Key Company Analysis
- Global Xerostomia (Dry Mouth) Market Sales Analysis by Product ($ Million)
- Artificial Saliva / Saliva Substitutes
- Salivary Stimulants / Sialogogues
- Biologic / Regenerative Therapies
- Global Xerostomia (Dry Mouth) Market Sales Analysis by Drug Type ($ Million)
- Over?the?Counter (OTC)
- Prescription
- Global Xerostomia (Dry Mouth) Market Sales Analysis by Formulation ($ Million)
- Sprays
- Mouthwashes / Rinses
- Gels
- Lozenges / Tablets
- Others (Mouthwashes / Oral Rinses, and Oral Liquids)
- Global Xerostomia (Dry Mouth) Market Sales Analysis by Distribution Channel ($ Million)
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies / E?commerce
- Regional Analysis
- North American Xerostomia (Dry Mouth) Market Sales Analysis – Product | Drug Type | Formulation | Distribution Channel | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Xerostomia (Dry Mouth) Market Sales Analysis – Product | Drug Type | Formulation | Distribution Channel | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Xerostomia (Dry Mouth) Market Sales Analysis – Product | Drug Type | Formulation | Distribution Channel | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Xerostomia (Dry Mouth) Market Sales Analysis – Product | Drug Type | Formulation | Distribution Channel | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- 3M Co.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Acacia Pharma Group plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bausch Health Co. Inc. (OraPharma)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Church & Dwight Co., Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cipla Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Colgate-Palmolive Co.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Dentaid Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Forward Science
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GlaxoSmithKline plc (GSK) / Biotene
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hikma Pharmaceuticals PLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lupin Pharmaceuticals, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Mission Pharmacal Co.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- OraCoat (Quest Products, LLC)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Parnell Pharmaceuticals, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pendopharm (Pharmascience Inc.)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Procter & Gamble Company (P&G)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Saliwell Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sun Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sunstar Suisse S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Synedgen Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- 3M Co.
1. Global Xerostomia (Dry Mouth) Market Research and Analysis by Product, 2025–2035 ($ Million)
2. Global Artificial Saliva / Saliva Substitutes Xerostomia (Dry Mouth) Market Research And Analysis By Region, 2025–2035 ($ Million)
3. Global Salivary Stimulants / Sialogogues Xerostomia (Dry Mouth) Market Research And Analysis By Region, 2025–2035 ($ Million)
4. Global Biologic / Regenerative Therapies Xerostomia (Dry Mouth) Market Research And Analysis By Region, 2025–2035 ($ Million)
5. Global Xerostomia (Dry Mouth) Market Research and Analysis by Drug Type, 2025–2035 ($ Million)
6. Global Over?the?Counter (OTC) Xerostomia (Dry Mouth)Market Research And Analysis By Region, 2025–2035 ($ Million)
7. Global Prescription Xerostomia (Dry Mouth) Market Research And Analysis By Region, 2025–2035 ($ Million)
8. Global Xerostomia (Dry Mouth) Market Research and Analysis by Formulation, 2025–2035 ($ Million)
9. Global Sprays For Xerostomia (Dry Mouth) Market Research And Analysis By Region, 2025–2035 ($ Million)
10. Global Mouthwashes / Rinses For Xerostomia (Dry Mouth)Market Research And Analysis By Region, 2025–2035 ($ Million)
11. Global Gels For Xerostomia (Dry Mouth) Market Research And Analysis By Region, 2025–2035 ($ Million)
12. Global Lozenges / Tablets For Xerostomia (Dry Mouth) Market Research And Analysis By Region, 2025–2035 ($ Million)
13. Global Other Formulation Xerostomia (Dry Mouth) Market Research And Analysis By Region, 2025–2035 ($ Million)
14. Global Xerostomia (Dry Mouth) Market Research and Analysis by Distribution Channel, 2025–2035 ($ Million)
15. Global Xerostomia (Dry Mouth) For Hospital Pharmacies Market Research And Analysis By Region, 2025–2035 ($ Million)
16. Global Xerostomia (Dry Mouth) For Retail Pharmacies & Drug Stores Market Research And Analysis By Region, 2025–2035 ($ Million)
17. Global Xerostomia (Dry Mouth) For Online Pharmacies / E?commerce Market Research And Analysis By Region, 2025–2035 ($ Million)
18. Global Xerostomia (Dry Mouth) Market Research and Analysis by Region, 2025–2035 ($ Million)
19. North American Xerostomia (Dry Mouth) Market Research and Analysis by Product, 2025–2035 ($ Million)
20. North American Xerostomia (Dry Mouth) Market Research and Analysis by Drug Type, 2025–2035 ($ Million)
21. North American Xerostomia (Dry Mouth) Market Research and Analysis by Formulation, 2025–2035 ($ Million)
22. North American Xerostomia (Dry Mouth) Market Research and Analysis by Distribution Channel, 2025–2035 ($ Million)
23. European Xerostomia (Dry Mouth) Market Research and Analysis by Product, 2025–2035 ($ Million)
24. European Xerostomia (Dry Mouth) Market Research and Analysis by Drug Type, 2025–2035 ($ Million)
25. European Xerostomia (Dry Mouth) Market Research and Analysis by Formulation, 2025–2035 ($ Million)
26. European Xerostomia (Dry Mouth) Market Research and Analysis by Distribution Channel, 2025–2035 ($ Million)
27. Asia-Pacific Xerostomia (Dry Mouth) Market Research and Analysis by Product, 2025–2035 ($ Million)
28. Asia-Pacific Xerostomia (Dry Mouth) Market Research and Analysis by Drug Type, 2025–2035 ($ Million)
29. Asia-Pacific Xerostomia (Dry Mouth) Market Research and Analysis by Formulation, 2025–2035 ($ Million)
30. Asia-Pacific Xerostomia (Dry Mouth) Market Research and Analysis by Distribution Channel, 2025–2035 ($ Million)
31. Rest of the World Xerostomia (Dry Mouth) Market Research and Analysis by Region, 2025–2035 ($ Million)
32. Rest of the World Xerostomia (Dry Mouth) Market Research and Analysis by Product, 2025–2035 ($ Million)
33. Rest of the World Xerostomia (Dry Mouth) Market Research and Analysis by Drug Type, 2025–2035 ($ Million)
34. Rest of the World Xerostomia (Dry Mouth) Market Research and Analysis by Formulation, 2025–2035 ($ Million)
35. Rest of the World Xerostomia (Dry Mouth) Market Research and Analysis by Distribution Channel, 2025–2035 ($ Million)
1. Global Xerostomia (Dry Mouth) Market Share by Product, 2025 vs 2035 (%)
2. Global Artificial Saliva / Saliva Substitutes Xerostomia (Dry Mouth) Market Share by Region, 2025 vs 2035 (%)
3. Global Salivary Stimulants / Sialogogues Xerostomia (Dry Mouth) Market Share by Region, 2025 vs 2035 (%)
4. Global Biologic / Regenerative Therapies Xerostomia (Dry Mouth) Market Share by Region, 2025 vs 2035 (%)
5. Global Xerostomia (Dry Mouth) Market Share by Drug Type, 2025 vs 2035 (%)
6. Global Over?the?Counter (OTC) Xerostomia (Dry Mouth) Market Share by Region, 2025 vs 2035 (%)
7. Global Prescription Xerostomia (Dry Mouth) Market Share by Region, 2025 vs 2035 (%)
8. Global Xerostomia (Dry Mouth) Market Share by Formulation, 2025 vs 2035 (%)
9. Global Sprays For Xerostomia (Dry Mouth) Market Share by Region, 2025 vs 2035 (%)
10. Global Mouthwashes / Rinses For Xerostomia (Dry Mouth) Market Share by Region, 2025 vs 2035 (%)
11. Global Gels For Xerostomia (Dry Mouth) Market Share by Region, 2025 vs 2035 (%)
12. Global Lozenges / Tablets for Xerostomia (Dry Mouth) Market Share by Region, 2025 vs 2035 (%)
13. Global Other Formulation Xerostomia (Dry Mouth) Market Share by Region, 2025 vs 2035 (%)
14. Global Xerostomia (Dry Mouth) Market Share by Distribution Channel, 2025 vs 2035 (%)
15. Global Xerostomia (Dry Mouth) For Hospital Pharmacies Market Share by Region, 2025 vs 2035 (%)
16. Global Xerostomia (Dry Mouth) For Retail Pharmacies & Drug Stores Market Share by Region, 2025 vs 2035 (%)
17. Global Xerostomia (Dry Mouth) For Online Pharmacies / E?commerce Market Share by Region, 2025 vs 2035 (%)
18. Global Xerostomia (Dry Mouth) Market Share By Region, 2025 Vs 2035 (%)
19. US Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
20. Canada Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
21. UK Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
22. France Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
23. Germany Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
24. Italy Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
25. Spain Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
26. Russia Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
27. Rest of Europe Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
28. India Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
29. China Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
30. Japan Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
31. South Korea Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
32. Australia and New Zealand Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
33. ASEAN Economies Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
34. Rest of Asia-Pacific Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
35. Latin America Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
36. Middle East and Africa Xerostomia (Dry Mouth) Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
